Peptech name change to Arana Therapeutics
Peptech has announced an official name change to Arana Therapeutics. The company’s ASX code will change to AAH this week and its code on the London Stock Exchange has been changed to AAHx.
Arana Therapeutics, created by the merger of Peptech and EvoGenix in August 2007, is focused on developing antibody/protein-based new generation products and platforms for the treatment of inflammatory diseases and cancer.
“This final step in the merger of Peptech and EvoGenix creates a true global player in the antibody therapeutics sector,” said Robin Beaumont, chairman of Arana Therapeutics.
“As well as critical mass, Arana Therapeutics has the right mix of people, skills, technologies and, most importantly, financial backing to achieve international recognition. Our key focus now is to rapidly develop our exciting product pipeline.”
Illumina appoints Susan Martin as General Manager, ANZ
Most recently, Martin served as Managing Director, Australia and New Zealand at Johnson &...
Monash University signs MOU with TGA Academic Outreach Program
The program fosters collaboration across research, knowledge exchange and education to support...
Report: Economic value of NATA accreditation estimated at $488–712m annually
A UTS report has explored the economic and social value of National Association of Testing...
